<?xml version="1.0" encoding="UTF-8"?>
<ref id="joim13128-bib-0025">
 <label>25</label>
 <mixed-citation publication-type="miscellaneous" id="joim13128-cit-0025">
  <string-name>
   <surname>Konno</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Kimura</surname>
   <given-names>I</given-names>
  </string-name>, 
  <string-name>
   <surname>Uriu</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Fukushi</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Irie</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Koyanagi</surname>
   <given-names>Y</given-names>
  </string-name>
  <italic>et al</italic>
  <article-title>SARS‐CoV‐2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant</article-title>. bioRxiv. 
  <year>2020</year>: 2020.05.11.088179.
 </mixed-citation>
</ref>
